Z.ai’s GLM-Legal is a legal AI model built on GLM-5.3-Flash. It scores 19.2% all-pass on Harvey’s Legal Agent Benchmark, nearly 3x its base, at $0.15 per test. Access is by application.
A new sampling algorithm, the open-closed mod-minimizer, reduces the space required for genomic indexes by up to 18 percent ...
Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...
For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
As Billy Strings prepares to reopen the historic Tivoli Theatre with two sold-out performances Tuesday and Wednesday, the Tivoli Theatre Foundation is inviting the community to share in the ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
Billy Strings' late mother, Debra Apostol, introduced the three-time Grammy award-winning musician to alternative music early in his life. "I remember her playing [The Beatles'] White Album backwards ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...
Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results